Boston Scientific has entered into a series of agreements with a TriVascular, a Santa Rosa, CA, developer of percutaneous aortic aneurysm stent-grafts. The agreements include an investment in the company, exclusive international distribution rights, and an exclusive option to acquire the firm.
TriVascular’s first commercially available product is designed to enable a delivery catheter that is small enough (approximately 12 French) to allow a physician to make a small puncture in the leg instead of an incision. The firm successfully completed its first human implant in August 2002 and has received approval from the U. S. Food and Drug Administration to begin its U. S. clinical trial, according to Natick, MA-based Boston Scientific.
By AuntMinnie.com staff writersJanuary 14, 2003
Related Reading
Boston Scientific biliary stent approved, October 30, 2002
Cook wins German patent fight vs. Boston Scientific, June 6, 2002
Boston Scientific debuts IVUS product, August 28, 2001
Guidant gets clearance for biliary stent , June 20, 2001
Boston Scientific, Endotex team up in carotid stenting, July 25, 2001
Copyright © 2003 AuntMinnie.com
